Genitourinary syndrome of menopause (GSM) describes a set of symptoms that affect the genitourinary tract, including vaginal dryness, painful intercourse, and urinary problems. Menopause is a ...

General adaptation syndrome (GAS) describes the three-stage response your body goes through when under stress: alarm reaction (also called fight-or-flight), resistance (where your body recovers), and ...

Tree man syndrome, or epidermodysplasia verruciformis (EV), is a rare, incurable skin disorder that makes people highly susceptible to human papillomavirus (HPV) infection. The disease can lead to ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Mast cell activation syndrome, or disease (MCAS), is a condition that causes mast cells to release these substances too frequently, resulting in severe allergic reactions. After detecting an ...

TORCH syndrome may sound like one medical condition. But it’s actually a group of different infections. They're caused by tiny germs like bacteria, viruses, or parasites. The germs (pathogens ...

Though the exact mechanism of action is unclear, it is believed that in patients with Prader-Willi syndrome, diazoxide choline reduces hyperphagia through activation of the adenosine triphosphate ...

‘Princess Syndrome’ - a term used to describe a mindset of entitlement, dependency, and unrealistic expectations - can significantly impact personal and professional growth. It wouldn’t be an ...

Diazoxide choline extended-release is the first FDA-approved therapy to address hyperphagia in Prader-Willi syndrome. Soleno Therapeutics announced the medication will be available beginning in April.

for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome (PWS). Soleno expects VYKAT XR to be available in the U.S. beginning in April 2025.

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call and webcast today, March 26 th, at 5:30pm ET REDWOOD CITY, Calif., ...

Cochrane, 19, will become the first AFL player with Tourette’s syndrome when he runs out at Marvel Stadium. FOX FOOTY, available on Kayo Sports, is the only place to watch every match of every ...